Literature DB >> 7083145

Ovarian cancer and talc: a case-control study.

D W Cramer, W R Welch, R E Scully, C A Wojciechowski.   

Abstract

Opportunities for genital exposure to talc were assessed in 215 white females with epithelial ovarian cancers and in 215 control women from the general population matched by age, race, and residence. Ninety-two (42.8%) cases regularly used talc either as a dusting powder on the perineum or on sanitary napkins compared with 61 (28.4%) controls. Adjusted for parity and menopausal status, this difference yielded a relative risk of 1.92 (P less than 0.003) for ovarian cancer associated with these practices. Women who had regularly engaged in both practices had an adjusted relative risk of 3.28 (P less than 0.001) compared to women with neither exposure. This provides some support for an association between talc and ovarian cancer hypothesized because of the similarity of ovarian cancer to mesotheliomas and the chemical relation of talc to asbestos, a known cause of mesotheliomas. The authors also investigated opportunities for potential talc exposure from rubber products such as condoms or diaphragms or from pelvic surgery. No significant differences were noted between cases and controls in these exposures, although the intensity of talc exposure from these sources was likely affected by variables not assessed in this study.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083145     DOI: 10.1002/1097-0142(19820715)50:2<372::aid-cncr2820500235>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Fertility drugs and ovarian epithelial cancer: is there a link?

Authors:  R J Paulson
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

2.  Reimagining Our System for Public Health Protection.

Authors:  David Michaels
Journal:  Am J Public Health       Date:  2019-07       Impact factor: 9.308

Review 3.  Management of early carcinoma of the ovary.

Authors:  G W Chapman
Journal:  J Natl Med Assoc       Date:  1988-09       Impact factor: 1.798

4.  Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.

Authors:  Michelle L Kurta; Kirsten B Moysich; Joel L Weissfeld; Ada O Youk; Clareann H Bunker; Robert P Edwards; Francesmary Modugno; Roberta B Ness; Brenda Diergaarde
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-15       Impact factor: 4.254

5.  How to induce ovarian cancer: and how not to.

Authors:  J S Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

6.  Migration of Talc From the Perineum to Multiple Pelvic Organ Sites.

Authors:  Sandra A McDonald; Yuwei Fan; William R Welch; Daniel W Cramer; John J Godleski
Journal:  Am J Clin Pathol       Date:  2019-10-07       Impact factor: 2.493

Review 7.  Pharmacoeconomic considerations in treating ovarian cancer.

Authors:  D Bodurka-Bevers; C C Sun; D M Gershenson
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

8.  Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy.

Authors:  Allison F Vitonis; Linda Titus-Ernstoff; Daniel W Cramer
Journal:  Obstet Gynecol       Date:  2011-05       Impact factor: 7.661

9.  Body Powder and Ovarian Cancer Risk-What Is the Role of Recall Bias?

Authors:  Britton Trabert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-10       Impact factor: 4.254

Review 10.  Perineal talc use and ovarian cancer: a critical review.

Authors:  Joshua E Muscat; Michael S Huncharek
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.